SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial (vol 3, 100036, 2022)LANCET REGIONAL HEALTH - SOUTHEAST ASIAIF6.22022-12-010OAAI
SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trialLANCET REGIONAL HEALTH - SOUTHEAST ASIAIF6.22022-08-0126OAAI
Results of Randomized Double Blind Phase III trial of FDC of Remogliflozin Etabonate and Teneligliptin in T2DM patientsDIABETES RESEARCH AND CLINICAL PRACTICEIF7.42022-04-010OAAI
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled TrialDRUGSIF14.42020-03-1132OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向